PRSS1 mRNA expression level was examined by RT-qPCR, and the results confirmed its high expression in cancer tissues of cisplatin-resistant patients and low expression in cisplatin-sensitive patients, with a p-value of 0.035 (Figure 5A). The gene discussed is PRSS1; the disease is cancer.